Correll, Christoph U.
Chepke, Craig
Gionfriddo, Paul
Parks, Joe
Foxworth, Phyllis
Basu, Anirban
Brister, Teri S.
Brown, Dawn
Clarke, Christopher
Hassoun, Youssef
Article History
Received: 27 August 2021
Accepted: 17 December 2021
First Online: 10 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: C. U. Correll has been a consultant and/or advisor to or has received honoraria from: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Axsome, Damitsa, Gedeon Richter, Hikma, IntraCellular Therapies, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Medscape, Merck, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon, Sunovion, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of LB Pharma.C. Chepke has received grant support from Alkermes, Janssen, Otsuka, and Teva. He has been a consultant for Alkermes, Janssen, Lundbeck, Otsuka, and Teva. He has received payment or honoraria from Alkermes, Janssen, Lundbeck, Otsuka, and Teva and received support for attending meetings and/or travel from Janssen, Otsuka, and Teva. He served on a Data Safety Monitoring Board for Alkermes, Janssen, Lundbeck, Otsuka, and Teva and held a leadership or fiduciary role in the CURESZ Foundation. He received equipment, materials, drugs, medical writing, gifts, or other services from Teva.P. Gionfriddo has no disclosures to declare.J. Parks has been a consultant for Alkermes, Janssen, Lundbeck, and Otsuka.P. Foxworth has received grant support from: AbbVie, Alkermes, Allergan, Axesome, BioXcel, Compass Pathways, Intra-Cellular, Janssen, LivaNova, Lundbeck, Myriad Genetics, Neurocrine Biosciences, Otsuka, Relmada, Sage, Sunovion, Takeda, and Teva.A. Basu has received funding as a consultant through Salutis Consulting.T. Brister has no disclosures to declare.D. Brown has no disclosures to declare.C. Clarke has received an honorarium from Lundbeck.Y. Hassoun has received payment or honoraria from Alkermes, Lundbeck, and Otsuka and served on a Data Safety Monitoring Board for Lundbeck and Otsuka.